Model-based approach for predicting the impact of genetic modifications on product yield in biopharmaceutical manufacturing-Application to influenza vaccine production.
A large group of biopharmaceuticals is produced in cell lines. The yield of such products can be increased by genetic engineering of the corresponding cell lines. The prediction of promising genetic modifications by mathematical modeling is a valuable tool to facilitate experimental screening. Besid...
Main Authors: | Stefanie Duvigneau, Robert Dürr, Tanja Laske, Mandy Bachmann, Melanie Dostert, Achim Kienle |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-06-01
|
Series: | PLoS Computational Biology |
Online Access: | https://doi.org/10.1371/journal.pcbi.1007810 |
Similar Items
-
Model-based analysis of influenza A virus replication in genetically engineered cell lines elucidates the impact of host cell factors on key kinetic parameters of virus growth.
by: Tanja Laske, et al.
Published: (2019-04-01) -
Cyberbiosecurity for Biopharmaceutical Products
by: Jennifer L. Mantle, et al.
Published: (2019-05-01) -
Globalization of biopharmaceutical manufacturing
by: Pande, Rachna
Published: (2012) -
Yeasts as Biopharmaceutical Production Platforms
by: Natalja Kulagina, et al.
Published: (2021-09-01) -
Process validation in manufacturing of biopharmaceuticals /
by: Rathore, Anurag S. (Anurag Singh), 1973- editor, et al.
Published: (2012)